Subhani M. Okarvi

1.6k total citations
46 papers, 1.2k citations indexed

About

Subhani M. Okarvi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Subhani M. Okarvi has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Radiology, Nuclear Medicine and Imaging, 23 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Subhani M. Okarvi's work include Radiopharmaceutical Chemistry and Applications (42 papers), Peptidase Inhibition and Analysis (19 papers) and Medical Imaging Techniques and Applications (13 papers). Subhani M. Okarvi is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (42 papers), Peptidase Inhibition and Analysis (19 papers) and Medical Imaging Techniques and Applications (13 papers). Subhani M. Okarvi collaborates with scholars based in Saudi Arabia, Canada and Belgium. Subhani M. Okarvi's co-authors include Melpomeni Fani, Helmut R. Maëcke, Ibrahim Al‐Jammaz, Suad Bin Amer, P. Adriaens, Alfons Verbruggen, Norah Alhokbany, David S. Wishart, S. Takács and Suzanne E. Lapi and has published in prestigious journals such as Molecules, Theranostics and Cancer Treatment Reviews.

In The Last Decade

Subhani M. Okarvi

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Subhani M. Okarvi Saudi Arabia 17 851 521 415 189 163 46 1.2k
Sandra Borkowski Germany 14 783 0.9× 522 1.0× 471 1.1× 205 1.1× 317 1.9× 16 1.3k
Annemarie Eek Netherlands 19 692 0.8× 501 1.0× 279 0.7× 325 1.7× 241 1.5× 28 1.2k
Michel Tohme United States 16 998 1.2× 423 0.8× 447 1.1× 100 0.5× 189 1.2× 23 1.5k
Sylvie Froidevaux Switzerland 15 794 0.9× 550 1.1× 414 1.0× 435 2.3× 110 0.7× 38 1.4k
Bogdan Mitran Sweden 25 1.1k 1.3× 688 1.3× 370 0.9× 120 0.6× 263 1.6× 55 1.3k
Alexandra D. Varvarigou Greece 19 733 0.9× 371 0.7× 214 0.5× 162 0.9× 216 1.3× 70 1.1k
Wilson B. Edwards United States 23 631 0.7× 414 0.8× 478 1.2× 130 0.7× 206 1.3× 59 1.5k
Ali Azhdarinia United States 25 637 0.7× 408 0.8× 387 0.9× 150 0.8× 263 1.6× 66 1.5k
Nellie K. Owen United States 16 766 0.9× 409 0.8× 285 0.7× 124 0.7× 206 1.3× 24 992
Tammy L. Rold United States 20 875 1.0× 585 1.1× 263 0.6× 193 1.0× 298 1.8× 34 1.2k

Countries citing papers authored by Subhani M. Okarvi

Since Specialization
Citations

This map shows the geographic impact of Subhani M. Okarvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhani M. Okarvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhani M. Okarvi more than expected).

Fields of papers citing papers by Subhani M. Okarvi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subhani M. Okarvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhani M. Okarvi. The network helps show where Subhani M. Okarvi may publish in the future.

Co-authorship network of co-authors of Subhani M. Okarvi

This figure shows the co-authorship network connecting the top 25 collaborators of Subhani M. Okarvi. A scholar is included among the top collaborators of Subhani M. Okarvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhani M. Okarvi. Subhani M. Okarvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okarvi, Subhani M. & Ibrahim Al‐Jammaz. (2022). Synthesis, Radiolabeling, and Preclinical Evaluation of 68 Ga/ 177 Lu-Labeled Leuprolide Peptide Analog for the Detection of Breast Cancer. Cancer Biotherapy and Radiopharmaceuticals. 37(5). 372–383. 5 indexed citations
2.
Okarvi, Subhani M., et al.. (2021). Fast Fluorine-18 labeling and preclinical evaluation of novel Mucin1 and its Folate hybrid peptide conjugate for targeting breast carcinoma. EJNMMI Radiopharmacy and Chemistry. 6(1). 12–12. 3 indexed citations
3.
Okarvi, Subhani M. & Ibrahim Al‐Jammaz. (2019). Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas. Molecules. 24(17). 3142–3142. 25 indexed citations
4.
6.
Okarvi, Subhani M., et al.. (2016). Development of a nickel plated aluminum krypton-81m target system. Applied Radiation and Isotopes. 121. 6–11. 1 indexed citations
7.
Al‐Jammaz, Ibrahim, et al.. (2014). Development and pre-clinical evaluation of new 68Ga-NOTA-folate conjugates for PET imaging of folate receptor-positive tumors.. PubMed. 34(11). 6547–56. 22 indexed citations
8.
Al‐Jammaz, Ibrahim, et al.. (2014). Development and preclinical evaluation of new 124I-folate conjugates for PET imaging of folate receptor-positive tumors. Nuclear Medicine and Biology. 41(6). 457–463. 10 indexed citations
9.
Al‐Jammaz, Ibrahim, et al.. (2014). Rapid and one-step radiofluorination of bioactive peptides: Potential PET radiopharmaceuticals. Applied Radiation and Isotopes. 91. 17–23. 5 indexed citations
10.
Amer, Suad Bin, et al.. (2012). Novel synthesis and preclinical evaluation of folic acid derivatives labeled with 18F-[FDG] for PET imaging of folate receptor-positive tumors. Nuclear Medicine and Biology. 39(6). 864–870. 26 indexed citations
11.
Fani, Melpomeni, Helmut R. Maëcke, & Subhani M. Okarvi. (2012). Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer. Theranostics. 2(5). 481–501. 264 indexed citations
12.
Amer, Suad Bin, et al.. (2011). Rapid synthesis and in vitro and in vivo evaluation of folic acid derivatives labeled with fluorine-18 for PET imaging of folate receptor-positive tumors. Nuclear Medicine and Biology. 38(7). 1019–1028. 23 indexed citations
13.
Okarvi, Subhani M., et al.. (2009). Design, synthesis, radiolabeling and in vitro and in vivo characterization of tumor-antigen- and antibody-derived peptides for the detection of breast cancer.. PubMed. 29(4). 1399–409. 13 indexed citations
14.
Okarvi, Subhani M., et al.. (2006). Preparation and In Vitro and In Vivo Evaluation of Technetium- 99m -Labeled Folate and Methotrexate Conjugates as Tumor Imaging Agents. Cancer Biotherapy and Radiopharmaceuticals. 21(1). 49–60. 44 indexed citations
15.
Okarvi, Subhani M.. (2004). Synthesis, radiolabeling and in vitro and in vivo characterization of a technetium‐99m‐labeled alpha‐M2 peptide as a tumor imaging agent. Journal of Peptide Research. 63(6). 460–468. 17 indexed citations
16.
Okarvi, Subhani M., P. Adriaens, & Alfons Verbruggen. (2002). Synthesis, radiolabelling characteristics and biological evaluation of the derivatives of mercaptoacetyltriglycine. Radiochimica Acta. 90(7). 423–429. 6 indexed citations
17.
Okarvi, Subhani M., Kristin Verbeke, P. Adriaens, & Alfons Verbruggen. (2002). Synthesis, labelling and biological characteristics of derivatives of Mercaptoacetyltriglycine with two amide functions. Journal of Labelled Compounds and Radiopharmaceuticals. 45(2). 115–137. 5 indexed citations
18.
Okarvi, Subhani M.. (2000). Synthesis and biological evaluation of bombesin peptide analogs radiolabelled with Tc-99m. Nuclear Medicine Communications. 21(6). 576–577. 3 indexed citations
19.
Okarvi, Subhani M., et al.. (1997). Radiolabelling characteristics of novel iminophosphorane ligands with technetium-99m. Journal of Labelled Compounds and Radiopharmaceuticals. 39(10). 833–851. 1 indexed citations
20.
Okarvi, Subhani M., et al.. (1992). Labeling and biodistribution in mice of terminal oxamide derivatives of tc-99m-mag3. European Journal of Nuclear Medicine and Molecular Imaging. 19(8). 591–591. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026